Terms: = Ovarian cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
346 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
[TBL] [Abstract] [Full Text] [Related]
3. Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and fas inhibition.
Montalvo MJ; Bandey IN; Rezvan A; Wu KL; Saeedi A; Kulkarni R; Li Y; An X; Sefat KMSR; Varadarajan N
Cell Death Dis; 2024 Feb; 15(2):109. PubMed ID: 38307835
[TBL] [Abstract] [Full Text] [Related]
4. Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.
Grunt TW; Wagner R; Ries A; Berghoff AS; Preusser M; Grusch M; Valent P
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38214315
[TBL] [Abstract] [Full Text] [Related]
5. ovarian cancer treatment and natural killer cell-based immunotherapy.
Fan Z; Han D; Fan X; Zhao L
Front Immunol; 2023; 14():1308143. PubMed ID: 38187402
[TBL] [Abstract] [Full Text] [Related]
6. Relationship between frailty and nutrition: Refining predictors of mortality after primary cytoreductive surgery for ovarian cancer.
Chauhan S; Langstraat CL; Fought AJ; McGree ME; Cliby WA; Kumar A
Gynecol Oncol; 2024 Jan; 180():126-131. PubMed ID: 38091771
[TBL] [Abstract] [Full Text] [Related]
7. Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer.
Yu HY; Yang L; Liu YC; Yu AJ
PeerJ; 2023; 11():e16308. PubMed ID: 38025760
[TBL] [Abstract] [Full Text] [Related]
8. Mesenchymal Stem Cell Microvesicles from Adipose Tissue: Unraveling Their Impact on Primary ovarian cancer Cells and Their Therapeutic Opportunities.
Szyposzynska A; Bielawska-Pohl A; Murawski M; Sozanski R; Chodaczek G; Klimczak A
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958844
[TBL] [Abstract] [Full Text] [Related]
9. Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.
Tassi E; Bergamini A; Wignall J; Sant'Angelo M; Brunetto E; Balestrieri C; Redegalli M; Potenza A; Abbati D; Manfredi F; Cangi MG; Magliacane G; Scalisi F; Ruggiero E; Maffia MC; Trippitelli F; Rabaiotti E; Cioffi R; Bocciolone L; Candotti G; Candiani M; Taccagni G; Schultes B; Doglioni C; Mangili G; Bonini C
Front Immunol; 2023; 14():1212444. PubMed ID: 37868997
[TBL] [Abstract] [Full Text] [Related]
10. Characterizing the regulatory fas (cd95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.
Mondal T; Gaur H; Wamba BEN; Michalak AG; Stout C; Watson MR; Aleixo SL; Singh A; Condello S; Faller R; Leiserowitz GS; Bhatnagar S; Tushir-Singh J
Cell Death Differ; 2023 Nov; 30(11):2408-2431. PubMed ID: 37838774
[TBL] [Abstract] [Full Text] [Related]
11. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.
Wang Y; Xie L; Liu F; Ding D; Wei W; Han F
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117299. PubMed ID: 37816474
[TBL] [Abstract] [Full Text] [Related]
12. Dietary Quality and Circulating Lipidomic Profiles in 2 Cohorts of Middle-Aged and Older Male Finnish Smokers and American Populations.
Zhang T; Naudin S; Hong HG; Albanes D; Männistö S; Weinstein SJ; Moore SC; Stolzenberg-Solomon RZ
J Nutr; 2023 Aug; 153(8):2389-2400. PubMed ID: 37328109
[TBL] [Abstract] [Full Text] [Related]
13. Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study.
Lindgren A; Anttila M; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
Eur J Radiol; 2023 Aug; 165():110925. PubMed ID: 37320880
[TBL] [Abstract] [Full Text] [Related]
14. Optimization of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer.
Flaum N; Bowes J; Smith MJ; Crosbie EJ; Edmondson R; Lophatananon A; Evans DG
Genet Med; 2023 Sep; 25(9):100898. PubMed ID: 37212253
[TBL] [Abstract] [Full Text] [Related]
15. Oleic acid stimulates cell proliferation and BRD4-L-MYC-dependent glucose transporter transcription through PPARα activation in ovarian cancer cells.
Kado T; Kusakari N; Tamaki T; Murota K; Tsujiuchi T; Fukushima N
Biochem Biophys Res Commun; 2023 May; 657():24-34. PubMed ID: 36965420
[TBL] [Abstract] [Full Text] [Related]
16. Yamogenin-Induced Cell Cycle Arrest, Oxidative Stress, and Apoptosis in Human ovarian cancer Cell Line.
Stefanowicz-Hajduk J; Hering A; Gucwa M; Czerwińska M; Ochocka JR
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500274
[TBL] [Abstract] [Full Text] [Related]
17. Superior Anticancer Potential of Nano-Paclitaxel Combined Bevacizumab Treatment in ovarian cancer.
Qu N; Wang C; Meng Y; Gao Y
Curr Pharm Biotechnol; 2023; 24(9):1204-1212. PubMed ID: 36221878
[TBL] [Abstract] [Full Text] [Related]
18. Clinico-genomic Characterization of ATM and HRD in Pancreas cancer: Application for Practice.
Park W; O'Connor CA; Bandlamudi C; Forman D; Chou JF; Umeda S; Reyngold M; Varghese AM; Keane F; Balogun F; Yu KH; Kelsen DP; Crane C; Capanu M; Iacobuzio-Donahue C; O'Reilly EM
Clin Cancer Res; 2022 Nov; 28(21):4782-4792. PubMed ID: 36040493
[TBL] [Abstract] [Full Text] [Related]
19. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases.
Han L; Guo X; Du R; Guo K; Qi P; Bian H
J Ovarian Res; 2022 Jun; 15(1):75. PubMed ID: 35739532
[TBL] [Abstract] [Full Text] [Related]
20. The anti-ovarian carcinoma activity of L-amino acid oxidase from Crotalus adamanteus venom in vivo and in vitro.
Xiong Y; He Q; Yu X; Li B; Song Z
Med Oncol; 2022 Jun; 39(8):112. PubMed ID: 35666342
[TBL] [Abstract] [Full Text] [Related]
[Next]
